NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Biotechnology

NewLimit

NewLimit's headquarters in South San Francisco, CA, United States

Brian Armstrong

Alex Kim

Burak Dura

Group Leader, Functional Genomics

Group Leader, Immunology

Head Of Computational Sciences

Operations Specialist

Scientist, Lipid Nano Particle Delivery

Group Leader, Machine Learning

Scientist/senior Scientist, Immunology

Description

People (11)

Burak Dura

David Reynolds

Nicholas Bernstein

Wesley McKeithan

Jenna Wolfley

Jenny Ng

Justin Juang

Nader Alerasool

Blake Byers

Jacob Kimmel

Ryan Theisen

Jobs (8)

Group Leader, Functional Genomics

Group Leader, Immunology

Head Of Computational Sciences

Operations Specialist

Scientist, Lipid Nano Particle Delivery

Operations Specialist

Group Leader, Machine Learning

Scientist/senior Scientist, Immunology